SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-21-170995
Filing Date
2021-05-24
Accepted
2021-05-24 16:51:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 425 d152426d425.htm 425 18892
  Complete submission text file 0001193125-21-170995.txt   20554
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filed by) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 425 | Act: 34 | File No.: 001-37569 | Film No.: 21955684
SIC: 2834 Pharmaceutical Preparations